Pmda - Pharmaceuticals and Medical Devices Agency
Menu
Close

Regulatory Science/The Science Board/Standard Development

The 1st Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes

Press Release

August 4, 2021 from 2pm to 4pm
Given the impact of COVID-19, the conference was held online.

Agenda / List of Handouts

Agenda
  1. Introduction of the Subcommittee Members
  2. About the Science Board
  3. Purpose, Work and Schedule for the Subcommittee
    • Issues Concerning Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes (Professor TAKAKURA, Chairperson of the Subcommittee)
  4. Lecture on Extracellular Vesicles (EVs) Including Exosomes and Discussion
    • Process of Manufacturing the Therapeutic Formulation of Extracellular Vesicles (EVs) and Challenges for Practical Use (Professor OCHIYA Takahiro of Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University)
  5. Others
 
List of Handouts
  • Document 1 Member List of the Subcommittee
  • Document 2 About the Science Board
  • Document 3 Lecture Materials by Professor TAKAKURA (Chairperson of the Subcommittee)
  • Document 4 Lecture Materials by Professor OCHIYA
  • Ref.1 PMDA Science Board Rules
  • Ref.2 PMDA Science Board Subcommittee Rules
  • Ref.3 Rules for Commissioning Members of the Science Board and the Subcommittees
  • Ref.4 Memorandum of Understanding on Disclosure of Minutes and Handouts
  • Ref.5 Memorandum of Understanding for Requesting Attendance of External Experts
  • Ref.6 Memorandum of Understanding on Management of Working Group
  • Ref.7 Examples of Outcome Documents, MHLW Administrative Notice and Article Publications from the Past Science Board Subcommittee